USFDA accepts Sun Pharma arm's ophthalmic drug applicationSun Pharma said that post the USFDA approval, OTX-101 will be commercialised in the US by Sun Ophthalmics, the branded ophthalmics division...
27 Dec, 2017, 11.50 AM IST
Sun Pharma gains on USFDA nod for eyecare drug BromSiteCountry’s biggest pharma company's shares surget up to 2% today. Sun Pharma received the USFDA nod to sell eyecare drug BromSite in the Uni...
11 Apr, 2016, 04.26 PM IST
USFDA nod for eyecare drug BromSite gives boost to Sun PharmaThe product will be commercialized through New Jersey-based Sun Ophthalmics, a division that Sun formed recently to route its specialty bra...
11 Apr, 2016, 01.59 AM IST
Sun Pharma completes acquisition of InSite VisionThe company said each issued and outstanding share of InSite common stock... was converted into the right to receive $0.35 as a result of t...
03 Nov, 2015, 11.51 AM IST
Sun Pharma makes tender offer to acquire InSite VisionSun Pharmaceutical Industries has made a tender offer to acquire US-based eyecare firm InSite Vision for USD 0.35 per share in cash.
29 Sep, 2015, 08.07 PM IST
Allergan Inc eyes Rs 1,000 crore in revenues from India by 2017-18"Our dream is to touch Rs 1,000 crore revenue figure by 2017-18. We are on track to get it on the back of what we have created here."
24 Aug, 2014, 01.06 PM IST
- Wellness market may touch $20 billion in next 3-4 yrs
Currently the size of the wellness market in India stood at about $ 10 billion, Allergan India Managing Director Raghu Kumar said.
01 Jan, 2012, 04.34 PM IST
- After Birla Pacific Spa and Talwalkars niche beauty and wellness companies planning for IPO
A pharmacy, a beauty salon and an eyecare chain figure among five niche companies planning IPOs in the next 12 months.
25 Aug, 2011, 09.44 AM IST
- Bausch & Lomb enters Pharmaceutical market
Eyecare firm Bausch & Lomb has entered into a drug supply deal with Bangalore-based Micro Labs, marking its entry into the country’s pharma...
01 Jul, 2011, 04.39 AM IST
- Novartis concludes acquisition of 77% Alcon stake from Nestle
Novartis on Thursday said it has concluded a $28.3 billion deal with Alcon Inc that will give the Swiss drug-maker a controlling stake in t...
26 Aug, 2010, 09.54 PM IST
- Novartis says Q1 profit up 49 pc
Drug maker Novartis AG said on Tuesday that strong sales particularly of swine flu vaccine helped increase net profit by 49 per cent to $2....
20 Apr, 2010, 12.52 PM IST
- Novartis to fully integrate Alcon by end-2010
Swiss drug maker, Novartis, is looking at fully integrating US-based eye-care group Alcon from Nestle by the end of this year, a top compan...
17 Feb, 2010, 07.39 PM IST
- M&A volume touches 10-year high at $ 74.5 billion in 2010
As the global economy recovers from recession blues, more companies are going shopping abroad leading to the merger and acquisition (M&A) v...
13 Jan, 2010, 05.06 PM IST
- Novartis looks to buy out Alcon for $38.5 bn
Drug maker Novartis AG said Monday it plans to take over Alcon Inc. by paying $38.5 billion for the 77 percent stake.
04 Jan, 2010, 07.05 PM IST
- Novartis posts 32-pc rise in 3Q net profit
Drug maker Novartis AG on Monday reported a 32-per cent rise in net profit for the third quarter, thanks to strong sales and the weakness o...
20 Oct, 2008, 01.00 PM IST
- Sankara Nethralaya plans mega eye-care complex
Iconic eye-care hospital Sankara Nethralaya is finalising plans to develop Asia’s largest integrated eye-care facility in Kolkata.
20 Aug, 2007, 04.27 AM IST
- Bausch & Lomb plans pharma foray
Bausch & Lomb plans to enter the ophthalmic pharmaceutical market in India. As of now, its Indian subsidiary is engaged in two product line...
12 Jul, 2006, 01.32 AM IST